DE69824164D1 - Arzneizubereitungen zur behandlung sexueller funktionsstörungen - Google Patents

Arzneizubereitungen zur behandlung sexueller funktionsstörungen

Info

Publication number
DE69824164D1
DE69824164D1 DE69824164T DE69824164T DE69824164D1 DE 69824164 D1 DE69824164 D1 DE 69824164D1 DE 69824164 T DE69824164 T DE 69824164T DE 69824164 T DE69824164 T DE 69824164T DE 69824164 D1 DE69824164 D1 DE 69824164D1
Authority
DE
Germany
Prior art keywords
medicinal preparations
functional disorders
treating sexual
sexual functional
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69824164T
Other languages
English (en)
Other versions
DE69824164T2 (de
Inventor
Alan Drizen
Peter Rothbart
M Nath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAM Pharmaceutical Corp USA
Original Assignee
LAM Pharmaceutical Corp USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAM Pharmaceutical Corp USA filed Critical LAM Pharmaceutical Corp USA
Publication of DE69824164D1 publication Critical patent/DE69824164D1/de
Application granted granted Critical
Publication of DE69824164T2 publication Critical patent/DE69824164T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69824164T 1997-03-28 1998-03-27 Arzneizubereitungen zur behandlung sexueller funktionsstörungen Expired - Fee Related DE69824164T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/825,121 US5952006A (en) 1995-09-29 1997-03-28 Drug preparations for treating impotency
US825121 1997-03-28
PCT/US1998/006020 WO1998043614A1 (en) 1997-03-28 1998-03-27 Drug preparations for treating sexual dysfunction

Publications (2)

Publication Number Publication Date
DE69824164D1 true DE69824164D1 (de) 2004-07-01
DE69824164T2 DE69824164T2 (de) 2005-07-07

Family

ID=25243165

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69824164T Expired - Fee Related DE69824164T2 (de) 1997-03-28 1998-03-27 Arzneizubereitungen zur behandlung sexueller funktionsstörungen

Country Status (11)

Country Link
US (1) US5952006A (de)
EP (1) EP0971694B1 (de)
JP (1) JP2002513410A (de)
AT (1) ATE267583T1 (de)
AU (1) AU750321B2 (de)
CA (1) CA2285181A1 (de)
DE (1) DE69824164T2 (de)
ES (1) ES2222581T3 (de)
IL (1) IL132115A0 (de)
PT (1) PT971694E (de)
WO (1) WO1998043614A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6063405A (en) * 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
ATE363292T1 (de) * 1998-09-04 2007-06-15 Scios Inc Hydrogelzusammensetzungen mit kontrollierter freigabe von wachstumsfaktoren
MXPA01010021A (es) * 1999-04-06 2002-07-30 Zonagen Inc Metodos para la modulacion de la respuesta sexual humana..
WO2001008659A1 (en) * 1999-07-30 2001-02-08 Lakefield Minerals Ltd. Pharmaceutical compositions for topical application to treat erectile dysfunction
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
AU2004208615C1 (en) * 2003-01-31 2010-05-13 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
WO2004089381A1 (en) 2003-04-02 2004-10-21 Nexmed (Holdings), Inc. Prostaglandin compositions and their use for the treatment of vasospasm
ATE536889T1 (de) * 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
FR2877574A1 (fr) * 2004-11-08 2006-05-12 Marie Claude Benattar Utilisation d'acide hyaluronique, eventuellement en association avec au moins un androgene pour le traitement de troubles sexuels ou urinaires feminins par amplification du point g et compositions.
US8703198B2 (en) 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US20060293236A1 (en) * 2005-06-23 2006-12-28 Prescott Albert G Injectable Osteogenic Formula and Method of Using Same
KR20130135994A (ko) * 2005-06-27 2013-12-11 다이이찌 산쿄 가부시키가이샤 안지오텐신 ⅱ 수용체 길항제 및 칼슘 채널 차단제를 함유한 약학 제제
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
GB0722507D0 (en) 2007-11-19 2007-12-27 Zhao Xiaobin Hyaluronic acid personal lubricant
BR112013025744A2 (pt) 2011-04-07 2016-08-16 Nexmed Holdings Inc composicões para tratamento da doença de raynaud
CA2896038C (en) * 2015-07-03 2022-08-09 Glycobiosciences Inc. Polymer matrix compositions comprising a high concentration of bio-fermented sodium hyaluronate and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
EP0266968A3 (de) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelierte Salbe mit einem Vasodilator
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5527893A (en) * 1987-09-18 1996-06-18 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US5017229A (en) * 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
IT1221826B (it) * 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
CH679670A5 (en) * 1990-10-01 1992-03-31 Applied Pharma Res Commercial carrageenan purificn. - by treatment with hydrogen peroxide in hydrated, inert organic solvent
EP0516026A1 (de) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel und Verfahren zu seiner Herstellung
WO1993000894A1 (en) * 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
KR940703666A (ko) * 1991-12-23 1994-12-12 로렌스 티. 웰츠 발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction)
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
GR1002418B (el) * 1992-07-29 1996-08-21 Johnson & Johnson Consumer Products Inc. Βιοεπισυναπτομενες συνθεσεις θεραπειας και μεθοδοι χρησης.
ATE236616T1 (de) * 1995-09-29 2003-04-15 Lam Pharmaceutical Corp Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten

Also Published As

Publication number Publication date
AU750321B2 (en) 2002-07-18
JP2002513410A (ja) 2002-05-08
ES2222581T3 (es) 2005-02-01
CA2285181A1 (en) 1998-10-08
WO1998043614A1 (en) 1998-10-08
AU6588198A (en) 1998-10-22
ATE267583T1 (de) 2004-06-15
US5952006A (en) 1999-09-14
IL132115A0 (en) 2001-03-19
DE69824164T2 (de) 2005-07-07
EP0971694B1 (de) 2004-05-26
PT971694E (pt) 2004-10-29
EP0971694A1 (de) 2000-01-19

Similar Documents

Publication Publication Date Title
DE69824164D1 (de) Arzneizubereitungen zur behandlung sexueller funktionsstörungen
GEP20043171B (en) Skin with a Minimal Systemic Effect
BR9812134A (pt) Composição farmacêutica para tratamento de dismenorréia e parto prematuro
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
ATE304845T1 (de) Hautpflaster enthaltend testosteron und gegebenenfalls estrogen
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DK1014954T3 (da) Transdermalt terapeutisk system
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
NO964527L (no) Blandinger omfattende DNA-ödeleggende midler og P53
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
PT946143E (pt) Composicao gelificada a base de nitro-imidazole.
PT941085E (pt) Dispositivo para administracao electricamente assistida de agentes como a lidocaina e a epinefrina
NO20004419D0 (no) Ny anvendelse
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
FR2795645B1 (fr) Nouvelle association pharmaceutique a activite analgesique
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
RU94024337A (ru) Антиметастатическое средство
NO991047L (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
GEP20002177B (en) Ointment “Levaskani” for Treatment of Wounds and Burns
AU1290797A (en) Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee